Holen Sie sich die Stockscreener-App
1.51
6.21%
-0.10
Handel nachbörslich:
1.57
0.06
+3.97%
Schlusskurs vom Vortag:
$1.61
Offen:
$1.63
24-Stunden-Volumen:
279.51K
Relative Volume:
0.79
Marktkapitalisierung:
$74.98M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-56.85M
KGV:
-0.9686
EPS:
-1.559
Netto-Cashflow:
-
1W Leistung:
-17.93%
1M Leistung:
-25.25%
6M Leistung:
-22.16%
1J Leistung:
-85.59%
1-Tages-Spanne:
$1.51
$1.64
1-Wochen-Bereich:
$1.51
$1.82
52-Wochen-Spanne:
$1.51
$10.69
Fractyl Health Inc Stock (GUTS) Company Profile
Firmenname
Fractyl Health Inc
Sektor
Branche
Telefon
781-902-8800
Adresse
3 VAN DE GRAAFF DRIVE, BURLINGTON
Vergleichen Sie GUTS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GUTS
Fractyl Health Inc
|
1.51 | 74.98M | 0 | -56.85M | 0 | -1.559 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.32 | 122.13B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
710.00 | 78.30B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
646.64 | 39.73B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
276.19 | 35.50B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
117.61 | 28.47B | 3.30B | -501.07M | 1.03B | -2.1146 |
Fractyl Health Inc Stock (GUTS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-02-28 | Eingeleitet | Evercore ISI | Outperform |
| 2024-02-27 | Eingeleitet | BofA Securities | Buy |
| 2024-02-27 | Eingeleitet | Morgan Stanley | Overweight |
Fractyl Health Inc Aktie (GUTS) Neueste Nachrichten
Fractyl Health (NASDAQ:GUTS) Price Target Cut to $10.00 by Analysts at Morgan Stanley - MarketBeat
Fractyl Health, Inc. (NASDAQ:GUTS) CEO Harith Rajagopalan Sells 90,972 Shares - MarketBeat
Potential Price Increase for Fractyl Health Inc (GUTS) After Recent Insider Activity - Knox Daily
BlackRock, Inc. Increases Stake in Fractyl Health Inc: A Strategic Move in Biotechnology - GuruFocus.com
Fractyl Health, Inc. (NASDAQ:GUTS) Stock Position Lifted by JPMorgan Chase & Co. - Defense World
Fractyl Health, Inc. (NASDAQ:GUTS) Insider Jay David Caplan Sells 22,346 Shares - MarketBeat
Fractyl Health Inc (GUTS) Stock: 52-Week Performance Showcases Highs, Lows, and Trading Volume - The InvestChronicle
Trading Day Triumph: Fractyl Health Inc (GUTS) Ends at 1.70, a -7.61 Surge/Plunge - The Dwinnex
Fractyl Health (NASDAQ:GUTS) Given New $10.00 Price Target at Morgan Stanley - Defense World
Fractyl Health announces layoffs as it pivots to gene therapy - Mass Device
Burlington biotech company announces layoffs, pivots research focus - NBC Boston
Fractyl Health Announces Increased Focus on Groundbreaking - GlobeNewswire
Fractyl Health pivots Type 2 diabetes device therapy toward obesity and GLP-1s, lays off 17% of staff - Fierce Biotech
Fractyl Health announces increased focus on Revita, Rejuva programs - TipRanks
Fractyl Health Reprioritizes Focus on REMAIN-1 Study - TipRanks
Weight Loss Breakthrough: Fractyl's Post-GLP-1 Maintenance Program Shows Promise as Company Pivots Strategy - StockTitan
Burlington biotech slims down 17% of workforce, focuses on weight maintenance treatment - The Business Journals
Barclays PLC Grows Position in Fractyl Health, Inc. (NASDAQ:GUTS) - Defense World
Fractyl Health, Inc. (NASDAQ:GUTS) Sees Large Growth in Short Interest - MarketBeat
Head-To-Head Analysis: Tactile Systems Technology (NASDAQ:TCMD) and Fractyl Health (NASDAQ:GUTS) - Defense World
Fractyl Health’s Promising Progress in Weight Management - TipRanks
Fractyl Health Announces Positive Initial Clinical Results Demonstrating Weight Maintenance Following GLP-1 Discontinuation and Revita Procedure in First Patient of the REVEAL-1 Cohort - The Manila Times
Fractyl Health Announces Positive Initial Clinical Results - GlobeNewswire
Fractyl Health Reports Breakthrough: Patient Maintains 15% Weight Loss After GLP-1 Discontinuation - StockTitan
Geode Capital Management LLC Has $1.27 Million Stock Position in Fractyl Health, Inc. (NASDAQ:GUTS) - MarketBeat
Geode Capital Management LLC Acquires 313,335 Shares of Fractyl Health, Inc. (NASDAQ:GUTS) - Defense World
Barclays PLC Has $121,000 Position in Fractyl Health, Inc. (NASDAQ:GUTS) - Defense World
Here’s Why Fractyl Health, Inc. (NASDAQ:GUTS) Is Among the Best Diabetes Stocks to Buy Under $10 - Insider Monkey
State Street Corp Purchases 63,968 Shares of Fractyl Health, Inc. (NASDAQ:GUTS) - Defense World
HighTower Advisors LLC Takes $38,000 Position in Fractyl Health, Inc. (NASDAQ:GUTS) - Defense World
BNP Paribas Financial Markets Increases Stake in Fractyl Health, Inc. (NASDAQ:GUTS) - Defense World
Charles Schwab Investment Management Inc. Has $204,000 Stock Position in Fractyl Health, Inc. (NASDAQ:GUTS) - Defense World
Critical Contrast: Fractyl Health (GUTS) and Its Rivals - Defense World
GUTSFractyl Health, Inc. Latest Stock News & Market Updates - StockTitan
Fractyl Health Unveils Promising Preclinical Data Demonstrating Safety and Feasibility of Local Delivery of RJVA-001 Rejuva® Smart GLP-1™ Pancreatic Gene Therapy at the World Congress Insulin Resistance, Diabetes and Cardiovascular Disease (WCIRD - GlobeNewswire
Fractyl Health Unveils Promising Preclinical Data Demonstrating Safety and Feasibility of Local - The Bakersfield Californian
Fractyl Health's GLP-1 Gene Therapy Shows Breakthrough Results in Preclinical Study5x Higher Expression - StockTitan
Fractyl Health to Present New Preclinical Data from its Rejuva® Single-Administration Smart GLP-1 Pancreatic Gene Therapy Platform at the World Congress Insulin Resistance, Diabetes and Cardiovascular Disease (WCIRDC) - The Manila Times
Fractyl Health to Present Breakthrough GLP-1 Gene Therapy Data for Diabetes Treatment at WCIRDC 2024 - StockTitan
Is Fractyl Health (NASDAQ:GUTS) Using Debt Sensibly? - Simply Wall St
Analysts Update Their Estimates For Alpha Teknova Inc - Stocks Register
Pulmonx (NASDAQ:LUNG) vs. Fractyl Health (NASDAQ:GUTS) Head-To-Head Review - Defense World
Fractyl Health to Participate in the Upcoming December Conferences - GlobeNewswire
Fractyl Health CEO to Present at Evercore, Piper Sandler Healthcare Conferences - StockTitan
Fractyl Health Stock Price Prediction: 2024, 2025, 2030 - Benzinga
Why This Penny Stock Lost 13% Last Week While Markets Soared - MSN
Comparing Fractyl Health (GUTS) and Its Rivals - Defense World
Comparing Fractyl Health (GUTS) and Its Peers - Defense World
Head to Head Analysis: Fractyl Health (GUTS) versus Its Peers - Defense World
Fractyl Health management to meet virtually with B. Riley - Nasdaq
Lee Ainslie's Strategic Reduction in Fractyl Health Inc Holdings - GuruFocus.com
Finanzdaten der Fractyl Health Inc-Aktie (GUTS)
Umsatz
Nettogewinn
Free Cashflow
ENV
Fractyl Health Inc-Aktie (GUTS) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Rajagopalan Harith | Chief Executive Officer |
Jan 30 '25 |
Option Exercise |
1.70 |
20,948 |
35,612 |
512,277 |
| Rajagopalan Harith | Chief Executive Officer |
Jan 31 '25 |
Sale |
1.82 |
90,972 |
165,205 |
491,329 |
| Rajagopalan Harith | Chief Executive Officer |
Jan 30 '25 |
Sale |
1.95 |
20,948 |
40,798 |
491,329 |
| Caplan Jay David | President, Chief Product Off. |
Jan 31 '25 |
Option Exercise |
1.70 |
22,346 |
37,988 |
175,890 |
| Caplan Jay David | President, Chief Product Off. |
Jan 30 '25 |
Option Exercise |
1.70 |
21,472 |
36,502 |
175,016 |
| Caplan Jay David | President, Chief Product Off. |
Jan 30 '25 |
Sale |
1.95 |
21,472 |
41,802 |
153,544 |
| Caplan Jay David | President, Chief Product Off. |
Jan 31 '25 |
Sale |
1.81 |
22,346 |
40,464 |
153,544 |
1.09%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):